Adc Therapeutics SA
ADCT
Get informed when a big investor buys or sells
+ FollowMarket Cap$164.08M
Close$
$-1.86
251.1% downside
Current Fair Value
251.1% downsideOvervalued by 251.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $164.08 Million |
|---|---|
| Enterprise Value | $354.42 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.12 |
| Beta | 1.88 |
| Outstanding Shares | 154,142,347 |
Return
| Return on Equity | 63.31% |
|---|---|
| Return on Assets | -47.00% |
| Return on Invested Capital | -47.86% |
Valuation & Multiples
| P/E Ratio | -1.23 |
|---|---|
| PEG | 8.4 |
| Price to Sales | - |
| Price to Book Ratio | -0.62 |
| Enterprise Value to Revenue | 4.48 |
| Enterprise Value to EBIT | -3.31 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 1.19 |
| Debt to Equity | -1.95 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
$19.99 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
$18.89 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 192,300▲ 426.85% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 65.72%▲ 4.99% |
|---|---|
| Total Invested | $312.90M▲ 6.85% |
| Investors Holding | 122▲ 5.00% |
ESG Score
No data